- Home
- YSG vs NRC Comparison
YSG vs NRC Comparison
Compare YSG & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YSG | NRC |
|---|---|---|
| Founded | 2016 | 1981 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 418.3M | 428.2M |
| IPO Year | 2020 | 1997 |
Fundamental Metrics
Financial Performance| Metric | YSG | NRC |
|---|---|---|
| Price | $3.75 | $15.67 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 93.1K | ★ 113.3K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | ★ 4.39% |
| EPS Growth | N/A | ★ 4707.69 |
| EPS | N/A | ★ 50.00 |
| Revenue | N/A | ★ $119,686,000.00 |
| Revenue This Year | $28.96 | N/A |
| Revenue Next Year | $16.57 | N/A |
| P/E Ratio | ★ N/A | $0.29 |
| Revenue Growth | N/A | ★ 1.81 |
| 52 Week Low | $3.30 | $9.76 |
| 52 Week High | $11.04 | $22.79 |
Technical Indicators
Market Signals| Indicator | YSG | NRC |
|---|---|---|
| Relative Strength Index (RSI) | 40.81 | 54.71 |
| Support Level | $3.30 | $14.78 |
| Resistance Level | $4.43 | $16.63 |
| Average True Range (ATR) | 0.22 | 0.84 |
| MACD | -0.04 | 0.46 |
| Stochastic Oscillator | 8.62 | 91.85 |
Price Performance
Historical ComparisonAbout YSG Yatsen Holding Limited
Yatsen Holding Ltd is engaged in the retail business of beauty products, skincare items, and other cosmetic products. The group's principal operations are currently organized into three segments on a product category basis, namely Color Cosmetics Brands, Skincare Brands, and others. The company's majority of revenue is generated from sales of Color Cosmetics Brands.
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.